{
    "clinical_study": {
        "@rank": "73712", 
        "acronym": "IMPROVED", 
        "arm_group": [
            {
                "arm_group_label": "Immediate treatment", 
                "arm_group_type": "Experimental", 
                "description": "Women in the Immediate treatment arm will receive the Group Psychoeducational treatment in the next available group. There will be 8-9 womenper group and each session will be 2.25 hours in duration and there will be 4, bi-weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, mindfulness practices, and cognitive techniques to notice thought patterns that contribute to increased pain."
            }, 
            {
                "arm_group_label": "Waitlist Control- delayed treatment", 
                "arm_group_type": "Experimental", 
                "description": "Women in the Waitlist Control arm will receive no treatment for a period of approximately 8 weeks. After the waitlist period they will receive the same Group Psychoeducational treatment as the participants in the immediate treatment arm of the study."
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to test the efficacy of a 4-session intervention (Group psychoeducational\n      treatment) using a randomized study design. Participants will be randomized in to 'immediate\n      treatment' or 'waitlist control'. Women in the wait-list condition will receive the\n      4-session IMPROVED treatment, just as women randomized to the experimental group, after the\n      end of their wait-list period."
        }, 
        "brief_title": "Integrated Mindfulness for Provoked Vestibulodynia", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Provoked Vestibulodynia", 
        "condition_browse": {
            "mesh_term": "Vulvodynia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  must be a patient at the British Columbia Centre for Sexual Medicine\n\n          -  diagnosis of provoked vestibulodynia (PVD)\n\n          -  19 years of age or older\n\n          -  premenopausal\n\n          -  fluent in English\n\n        Exclusion Criteria:\n\n          -  not at patient at the BC Centre for Sexual Medicine\n\n          -  unprovoked vulvar pain, other pathology causing pain with penetration, or chronic\n             pelvic pain\n\n          -  being uncomfortable and unwilling to participate in a group setting."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "97", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01704443", 
            "org_study_id": "H08-00885"
        }, 
        "intervention": [
            {
                "arm_group_label": "Immediate treatment", 
                "description": "The Group Psychoeducational Treatment consists of treatment in small group format (8-9 women). Each session will be 2.25 hours in duration and there will be four, bi-weekly sessions over the course of 2 months. Session content includes education about chronic pain, PVD, stress and sexual response, mindfulness practices, and cognitive techniques to notice thought patterns that contribute to increased pain.\nParticipants in the Waitlist Control Condition will receive this treatment at the end of the waitlist period (approximately 8 weeks)", 
                "intervention_name": "Group Psychoeducational Treatment", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Waitlist Control- delayed treatment", 
                "description": "No treatment will be provided during the 8 week Waitlist control period", 
                "intervention_name": "Waitlist control", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "provoked vestibulodynia", 
            "dyspareunia", 
            "vulvodynia", 
            "mindfulness", 
            "cognitive behavioural therapy"
        ], 
        "lastchanged_date": "June 3, 2013", 
        "link": {
            "url": "http://www.obgyn.ubc.ca/SexualHealth/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Vancouver", 
                    "country": "Canada", 
                    "state": "British Columbia", 
                    "zip": "V5Z 1M9"
                }, 
                "name": "British Columbia Centre for Sexual Medicine"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Integrated Mindfulness for Provoked Vestibulodynia", 
        "other_outcome": [
            {
                "description": "The investigators will examine women's self-reported pain catastrophising by administering the Pain Catastrophizing Scale (Sullivan, Bishop & Pivik, 1995).", 
                "measure": "Pain Catastrophising", 
                "safety_issue": "No", 
                "time_frame": "one week pre-treatment, one week  post treatment and 6-months follow-up"
            }, 
            {
                "description": "The investigators will examine women's self-report hypervigilance about pain by administering the Pain Vigilance and Awareness Questionnaire, McCracken, 1997)", 
                "measure": "Pain hypervigilance", 
                "safety_issue": "No", 
                "time_frame": "one week pre-treatment, one week post treatment and 6-months follow-up"
            }
        ], 
        "overall_official": {
            "affiliation": "University of British Columbia", 
            "last_name": "Lori A Brotto, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Pain intensity will be measured with the Q-tip test- a standard method of diagnosing vestibulodynia and assessing the pain associated with the diagnosis. The Q-tip test involves the physician lightly touching a Q-tip to specific areas around the vulvar vestibule while the patient indicates how much pain they feel on a scale from 0-10 in response to this provoked touch.", 
                "measure": "Pain intensity", 
                "safety_issue": "No", 
                "time_frame": "one week pre-treatment to one week post treatment"
            }, 
            {
                "description": "Pain intensity will be measured with the Q-tip test- a standard method of diagnosing vestibulodynia and assessing the pain associated with the diagnosis. The Q-tip test involves the physician lightly touching a Q-tip to specific areas around the vulvar vestibule while the patient indicates how much pain they feel on a scale from 0-10 in response to this provoked touch", 
                "measure": "Long-term pain intensity", 
                "safety_issue": "No", 
                "time_frame": "One week pre-treatment to 6 months post preatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01704443"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The investigators will examine women's self-reported sexual distress by administering the Female Sexual Distress Scale-Revised (Derogatis et al, 2008)", 
            "measure": "Sexual Distress", 
            "safety_issue": "No", 
            "time_frame": "One week pre-treatment, one week post treatment and 6-months follow up"
        }, 
        "source": "University of British Columbia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of British Columbia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}